John Vandermosten
Analyst
Zacks
Analyst
Zacks SCR
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Vandermosten
John Vandermosten is recorded as Analyst at Zacks and Analyst at Zacks SCR. John Vandermosten has spoken on 8 earnings calls across 4 companies, most recently for Protalix BioTherapeutics, Inc. on August 12, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Zacks
Analyst
Source not stated
Current -
Zacks SCR
Analyst
Transcript header (unverified)
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.